Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025
SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on […]
FangDD Announces US$5,000,000 Senior Convertible Notes Offering
SHENZHEN, China, March 14, 2025 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented […]
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition […]
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
– Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study –– Company expects to submit New Drug Application (NDA) […]
Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG, March 14, 2025 (GLOBE NEWSWIRE) — Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”) announced that, on March […]
AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results
MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of […]
Pilgrim’s Announces $1.5 Billion Special Dividend and Long-term Capital Allocation Strategy
GREELEY, Colo., March 14, 2025 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world’s leading food companies, […]
Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results
Quarterly total revenues reached RMB44.3 billion (US$6.1 billion)1Quarterly deliveries reached 158,696 vehiclesFull year total revenues reached RMB144.5 billion (US$19.8 billion)Full […]
Pioneering Autonomous Technology Drives Global Expansion and Commercial Market Growth
NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (Nasdaq: WRD) (“WeRide” or the “Company”), a global leader in […]
Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
